Coherus Biosciences Inc. appointed Dr. V. Bryan Lawlis, Jr. as Chairman to its Scientific Advisory Board. Dr. Lawlis, a biotech industry veteran, has extensive experience in manufacturing biotechnology and other pharmaceutical products, research and development of drug products, conducting clinical trials and the regulatory processes. Dr. Lawlis is a founder and currently serves as the President and Chief Executive Officer of Itero Biopharmaceuticals Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +9.09% |
|
+24.14% | -45.95% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.95% | 207M | |
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Coherus Biosciences Inc. Announces Appointment of V. Bryan Lawlis, Jr. as Chairman of its Scientific Advisory Board